Sex: F
Vaccine: COVID19, COVID19-2
Symptoms: Blood pressure measurement, COVID-19, Malaise, SARS-CoV-2 test
Clinical narrative: Felt very uncomfortable with all the Covid-19 vaccines; COVID-19 symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 symptoms) and MALAISE (Felt very uncomfortable with all the Covid-19 vaccines) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. A57167B, 0171422A, 054222A and 939903) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for an unknown indication.    Concurrent medical conditions included Atrial fibrillation (Taking blood thinners.) and Drug allergy (Allergic to Benadryl).   On 09-Jan-2021 at 4:30 PM, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 09-Feb-2021 at 5:15 PM, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 01-Jun-2022, received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2022 at 12:05 PM, received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 23-May-2023 at 12:00 PM, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 29-Dec-2022, the patient experienced COVID-19 (COVID-19 symptoms). On an unknown date, the patient experienced MALAISE (Felt very uncomfortable with all the Covid-19 vaccines). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19 treatment, at an unspecified dose and frequency and APIXABAN (ELIQUIS) for Atrial fibrillation, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19 symptoms) and MALAISE (Felt very uncomfortable with all the Covid-19 vaccines) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2023, SARS-CoV-2 test: Positive. On 12-Jul-2023, SARS-CoV-2 test: Positive. On an unknown date, Blood pressure measurement: 151 over.         No concomitant medications were reported.   It was reported that patient had 2 previous covid-19 vaccines. Patient had awful chills within 10 minutes and all the night, flu like headache and al that type for 3 days after the first dose of Pfizer vaccine. Patient had reactions with second vaccine in Feb-2021 i.e., chills, but next day woke up with swollen lips, tingling sensation, (thought that dry lips were not related to the vaccine) by 03:30 felt uncomfortable, mouth was still puffy and had flu symptoms for 3 days but had no fever. None of the covid-19 vaccines cause a fever.  Patient visited urgent care and pressure was 151 over something and they did neurological and don't know what to do. Patient was allergic to Benadryl and heart starts palpitating. It was told that have had allergic reaction to Pfizer and if throat begins to close visit to ER. After that had some flu like headache for days but survived it. Because of this patient was switched to moderna booster vaccines due to less invasive and less problematic. Patient was sensitive to drugs and had covid-19 twice. Beginning of Jan-2023, patient was very sick it went away for 8 days and felt bad. It was found that patient has covid-19 again. Patient also had a heart A-fib problem and discussed with cardiologist they prescribed to take half of the Eliquis and cholesterol medication. With all the covid-19 vaccines patient felt uncomfortable for 3-4 days afterwards.